PCa patients with “low or normal” serum PSA levels usually display higher neuroendocrine (NE) secretions and aggressive growth, suggesting that the genes associated with neuroendocrine features may help detect aggressive PCa [34,35,36]. This evidence concerns the gene KLK3 and posterior cortical atrophy.